ENTERPRISE THERAPEUTICS LTD
Get an alert when ENTERPRISE THERAPEUTICS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2027-05-16 (in 1y)
Last made up 2026-05-02
Watchouts
None on the register
Cash
£4M
-5% vs 2025
Net assets
-£21M
-21.5% lowest in 4 filed years
Employees
8
-11.1% vs 2025
Profit before tax
-£5M
-4.5% vs 2025
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2025-12-31
| Metric | Trend | 2023-01-01 | 2023-12-31 | 2024-01-01 | 2024-12-31 | 2025-06-30 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | £259,145 | |
| Operating profit | — | — | — | — | -£5,332,027 | -£4,563,242 | |
| Profit before tax | — | -£3,887,843 | — | -£7,215,668 | -£4,324,207 | -£4,517,205 | |
| Net profit | — | -£3,887,843 | — | -£7,215,668 | -£4,324,207 | -£3,747,618 | |
| Cash | — | £1,501,571 | — | £6,714,252 | £4,267,849 | £4,055,248 | |
| Total assets less current liabilities | — | — | — | — | — | — | |
| Net assets | — | -£5,766,320 | — | -£12,927,849 | -£17,229,752 | -£20,938,199 | |
| Equity | -£1,878,477 | -£17,298,960 | -£5,766,320 | -£38,783,547 | £0 | -£20,938,199 | |
| Average employees | — | 10 | — | 8 | 9 | 8 | |
| Wages | — | £1,507,638 | — | £1,702,215 | £848,473 | £823,696 | |
| Directors' remuneration | — | — | — | — | £241,991 | £141,239 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2025 → FY2025 · period ending 2025-12-31 vs 2025-06-30
-
Turnover
—
Not reported
-
Cash
-5%
£4,267,849 £4,055,248
-
Net assets
-21.5%
-£17,229,752 -£20,938,199
lowest in 4 filed years
-
Employees
-11.1%
9 8
-
Operating profit
+14.4%
-£5,332,027 -£4,563,242
-
Profit before tax
-4.5%
-£4,324,207 -£4,517,205
-
Wages
-2.9%
£848,473 £823,696
lowest in 4 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-01-01 | 2023-12-31 | 2024-01-01 | 2024-12-31 | 2025-06-30 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -1760.9% | |
| Net margin | — | — | — | — | — | -1446.1% | |
| Gearing (liabilities / total assets) | — | 294.4% | — | 223.1% | 336.0% | 448.6% | |
| Current ratio | — | — | — | — | 0.30x | 0.22x | |
| Interest cover | — | — | — | — | -4731.17x | -41864.61x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- James Cowper Kreston Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- ENTERPRISE THERAPEUTICS LTD · parent
- Enterprise Therapeutics Srl 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOYD, Philip James, Dr | Secretary | 2016-12-15 | — | — |
| FORD, John William, Dr | Director | 2016-11-03 | Jul 1974 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DANAHAY, Henry, Dr | Director | 2014-05-02 | 2014-12-08 |
| DZIKOWSKI, Bart | Director | 2020-01-01 | 2021-05-20 |
| FINAN, Peter Michael, Dr | Director | 2014-12-08 | 2021-05-20 |
| GOSLING, Martin, Dr | Director | 2014-05-02 | 2018-04-06 |
| MAYWEG, Alexander Volker, Dr | Director | 2018-04-06 | 2021-05-20 |
| MCCARTHY, Clive, Dr | Director | 2014-05-02 | 2014-12-08 |
| MORRIS, David | Director | 2018-04-06 | 2020-01-01 |
| MULDER, Geert-Jan | Director | 2018-04-06 | 2021-05-20 |
| MUNSHI, Amit | Director | 2019-04-02 | 2021-05-20 |
| RICHARDSON, Johnathan Craig, Dr | Director | 2019-09-10 | 2021-05-20 |
| ROPER, Elizabeth | Director | 2014-12-08 | 2019-04-02 |
| SONI, Bobby G., Dr | Director | 2018-04-06 | 2019-09-10 |
| STOREY, John Mervyn David, Professor | Director | 2014-05-02 | 2014-12-08 |
| WOODMAN, Robbie, Dr | Director | 2015-05-05 | 2018-02-15 |
| IP2IPO SERVICES LIMITED | Corporate Director | 2018-02-15 | 2018-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Enterprise Therapeutics Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-05 | Active |
| Ip2ipo Portfolio (Gp) Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2020-02-07 | Ceased 2020-10-05 |
| Touchstone Innovations Businesses Llp | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2020-10-05 |
| Epidarex Capital Partners Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2018-04-06 |
Filing timeline
Last 20 of 105 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-08-12 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-18 | AA | accounts | Accounts with accounts type full | |
| 2026-01-02 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-09-08 | AA | accounts | Accounts with accounts type full | |
| 2025-07-01 | AA01 | accounts | Change account reference date company previous shortened | |
| 2025-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-06 | AA | accounts | Accounts with accounts type full | |
| 2024-05-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-19 | AA | accounts | Accounts with accounts type full | |
| 2023-06-15 | AA | accounts | Accounts with accounts type full | |
| 2023-05-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-27 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2023-05-18 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2022-05-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-05 | AA | accounts | Accounts with accounts type full | |
| 2021-08-27 | AA | accounts | Accounts with accounts type full | |
| 2021-08-26 | CH01 | officers | Change person director company with change date | |
| 2021-08-12 | RESOLUTIONS | resolution | Resolution | |
| 2021-08-03 | TM01 | officers | Termination director company with name termination date | |
| 2021-08-03 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.